{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:09:55Z","timestamp":1787314195650,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.lfs.2022.120918","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T11:02:18Z","timestamp":1661598138000},"page":"120918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Dopamine receptor 3: A mystery at the heart of cardiac fibrosis"],"prefix":"10.1016","volume":"308","author":[{"given":"Shannon E.","family":"Byrne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Vishwakarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Sriramula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmansa C.","family":"Katwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120918_bb0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","author":"Beaulieu","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.lfs.2022.120918_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.07.003","article-title":"Dopamine outside the brain: the eye, cardiovascular system and endocrine pancreas","volume":"203","author":"Bucolo","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.lfs.2022.120918_bb0015","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0031-6997(25)07154-6","article-title":"Dopamine (3-HYDROXYTYRAMINE) and BRAIN function","volume":"18","author":"Hornykiewicz","year":"1966","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.lfs.2022.120918_bb0020","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00380-009-1224-4","article-title":"Dopamine receptor subtypes in the native human heart","volume":"25","author":"Cavallotti","year":"2010","journal-title":"Heart Vessel."},{"issue":"9","key":"10.1016\/j.lfs.2022.120918_bb0025","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.amjhyper.2006.03.005","article-title":"Correlation between striatal dopamine D2\/D3 receptor binding and cardiovascular activity in healthy subjects","volume":"19","author":"Yeh","year":"2006","journal-title":"Am. J. Hypertens."},{"issue":"6","key":"10.1016\/j.lfs.2022.120918_bb0030","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.01344.2007","article-title":"Inhibitory effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells","volume":"294","author":"Li","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120918_bb0035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5527\/wjn.v4.i2.196","article-title":"Renal dopaminergic system: pathophysiological implications and clinical perspectives","volume":"4","author":"Choi","year":"2015","journal-title":"World J. Nephrol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120918_bb0040","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbrc.2020.06.137","article-title":"Dopamine receptor D3 agonist (Pramipexole) reduces morphine-induced cardiac fibrosis","volume":"529","author":"Gaweda","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.lfs.2022.120918_bb0045","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1124\/mol.106.028951","article-title":"cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1\/2 and smad signaling in cardiac fibroblasts","volume":"70","author":"Liu","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120918_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2018.00199","article-title":"Differential dopamine D1 and D3 receptor modulation and expression in the spinal cord of two mouse models of restless legs syndrome","volume":"12","author":"Meneely","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.lfs.2022.120918_bb0055","first-page":"s10","article-title":"Role of dopamine in the pathogenesis of hypertension","volume":"26","author":"Jose","year":"1999","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.lfs.2022.120918_bb0060","first-page":"37","article-title":"Side effects of a dopamine agonist therapy for Parkinson\u2019s disease: a mini-review of clinical pharmacology","volume":"89","author":"Borovac","year":"2016","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.lfs.2022.120918_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson\u2019s disease","volume":"356","author":"Zanettini","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2022.120918_bb0070","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00023210-200721050-00008","article-title":"Pramipexole: in restless legs syndrome","volume":"21","author":"Mccormack","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.lfs.2022.120918_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(98)00307-4","article-title":"Pramipexole\u2013a new dopamine agonist for the treatment of Parkinson\u2019s disease","volume":"163","author":"Bennett","year":"1999","journal-title":"J. Neurol. Sci."},{"issue":"13","key":"10.1016\/j.lfs.2022.120918_bb0080","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1503\/cmaj.1041064","article-title":"Modern antipsychotics drugs: a critical overview","volume":"172","author":"Gardner","year":"2005","journal-title":"Can. Med. Assoc. J."},{"issue":"1","key":"10.1016\/j.lfs.2022.120918_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1176\/appi.focus.20200051","article-title":"Contrasting typical and atypical antipsychotic drugs","volume":"19","author":"Meltzer","year":"2021","journal-title":"Focus"},{"key":"10.1016\/j.lfs.2022.120918_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4172\/2471-271X.1000120","article-title":"Dopamine: receptors, functions, synthesis, pathways, locations and mental disorders: review of literatures","volume":"2","author":"Ayano","year":"2016","journal-title":"J. Ment. Disord. Treat"},{"issue":"8","key":"10.1016\/j.lfs.2022.120918_bb0095","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3390\/molecules23082087","article-title":"Current concepts and treatments of Schizophrenia","volume":"23","author":"Stepnicki","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2022.120918_bb0100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1291\/hypres.30.93","article-title":"Arterial blood pressure and renal sodium excretion in dopamine D 3 receptor knockout mice","author":"Staudacher","year":"2007","journal-title":"Hypertens. Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.120918_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18128-x","article-title":"Cardiac dopamine D1 receptor triggers ventricular arrhythmia in chronic heart failure","volume":"11","author":"Yamaguchi","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.lfs.2022.120918_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12092436","article-title":"Targeting dopamine receptor d2 by imipridone suppresses uterine serous cancer malignant phenotype","volume":"12","author":"Hu","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2022.120918_bb0115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/HYPERTENSIONAHA.120.16738","article-title":"DRD4 (Dopamine D4 receptor) mitigate abdominal aortic aneurysm via decreasing P38 MAPK (mitogen-activated protein kinase)\/NOX4 (NADPH oxidase 4) axis-associated oxidative stress","author":"Liu","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2022.120918_bb0120","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.redox.2018.07.008","article-title":"Over-expression of a cardiac-specific human dopamine D5 receptor mutation in mice causes a dilated cardiomyopathy through ROS over-generation by NADPH oxidase activation and Nrf2 degradation","volume":"19","author":"Jiang","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2022.120918_bb0125","series-title":"Biomolecules","first-page":"1","article-title":"Dopamine D3 receptor heteromerization: implications for neuroplasticity and neuroprotection","author":"Mutti","year":"2020"},{"issue":"4","key":"10.1016\/j.lfs.2022.120918_bb0130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/aas.13294","article-title":"Dopamine in critically ill patients with cardiac dysfunction: a systematic review with meta-analysis and trial sequential analysis","volume":"63","author":"Hiemstra","year":"2019","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"7","key":"10.1016\/j.lfs.2022.120918_bb0135","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1460-9568.2008.06423.x","article-title":"Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation","volume":"28","author":"Collo","year":"2008","journal-title":"Eur. J. Neurosci."},{"issue":"9","key":"10.1016\/j.lfs.2022.120918_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092164","article-title":"ERK: a key player in the pathophysiology of cardiac hypertrophy","volume":"20","author":"Gallo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"732282","key":"10.1016\/j.lfs.2022.120918_bb0145","article-title":"Loss of function in dopamine D3 receptor attenuates left ventricular cardiac fibroblasts migration and proliferation in vitro","volume":"8","author":"Kisling","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.lfs.2022.120918_bb0150","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/01.HYP.0000114601.30306.bf","article-title":"Aberrant and D1 and D3 dopamine receptor transregulation in hypertension","volume":"43","author":"Zeng","year":"2004","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.lfs.2022.120918_bb0155","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1139\/y02-081","article-title":"Functional and autoradiographic characterization of dopamine D2-like receptors in the Guinea pig heart","volume":"80","author":"De Jes\u00fas G\u00f3mez","year":"2002","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120918_bb0160","first-page":"112","article-title":"The roles of dopamine receptor 3 in age- and sex-dependent left ventricular remodeling","author":"Grilo","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2022.120918_bb0165","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-008-0051-9","article-title":"Dopamine receptors and hypertension","author":"Banday","year":"2008","journal-title":"Curr. Hypertens. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2022.120918_bb0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/HYPERTENSIONAHA.110.157727","article-title":"Dopamine receptors: important antihypertensive counterbalance against hypertensive factors","volume":"57","author":"Zeng","year":"2011","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.lfs.2022.120918_bb0175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI3685","article-title":"Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension","volume":"102","author":"Asico","year":"1998","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.lfs.2022.120918_bb0180","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/ndt\/gfh174","article-title":"Dopamine D3 receptor gene polymorphisms, blood pressure and nephropathy in type 1 diabetic patients","volume":"19","author":"Pettersson-Fernholm","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2022.120918_bb0185","author":"Wang","year":"2013"},{"issue":"8","key":"10.1016\/j.lfs.2022.120918_bb0190","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/HJH.0000000000000986","article-title":"Effect of D3 dopamine receptor on dopamine D4 receptor expression and function in renal proximal tubule cells from wistar-Kyoto rats and spontaneously hypertensive rats","volume":"34","author":"Chen","year":"2016","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.lfs.2022.120918_bb0195","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/01.HYP.0000118958.27649.6f","article-title":"Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles","volume":"43","author":"Zeng","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2022.120918_bb0200","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1440-1681.2004.04095.x","article-title":"Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats","author":"Polakowski","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.lfs.2022.120918_bb0205","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau6296","article-title":"Selective YAP\/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis","author":"Haak","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"JUNE","key":"10.1016\/j.lfs.2022.120918_bb0210","article-title":"Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord","volume":"8","author":"Brewer","year":"2014","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.lfs.2022.120918_bb0215","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.neuroscience.2019.03.034","article-title":"Dopamine D1 and D3 receptor modulators restore morphine analgesia and prevent opioid preference in a model of neuropathic pain","volume":"406","author":"Rodgers","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.lfs.2022.120918_bb0220","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1152\/jn.00390.2015","article-title":"Opposing aging-related shift of excitatory dopamine D1 and inhibitory D3 receptor protein expression in striatum and spinal cord","volume":"115","author":"Keeler","year":"2016","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.lfs.2022.120918_bb0225","doi-asserted-by":"crossref","DOI":"10.1161\/01.HYP.0000199983.24674.83","article-title":"D3 dopamine receptor directly interacts with D1 dopamine receptor in immortalized renal proximal tubule cells","author":"Zeng","year":"2006","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.lfs.2022.120918_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074116","article-title":"The dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosis","volume":"8","author":"Johnson","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.lfs.2022.120918_bb0235","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00228-011-1084-6","article-title":"Dopamine agonists and ischemic complications in Parkinson's disease: a nested case-control study","volume":"68","author":"Arbouw","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120918_bb0240","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/mdc3.12286","article-title":"Associations between cardiovascular events and nonergot dopamine agonists in Parkinson's disease","volume":"3","author":"Crispo","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.lfs.2022.120918_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jcpt.12649","article-title":"Effects of dopamine receptor antagonist antipsychotic therapy on blood pressure","author":"Gonsai","year":"2018","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.lfs.2022.120918_bb0250","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson's disease","volume":"356","author":"Zanettini","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.lfs.2022.120918_bb0255","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.0000240500.96746.ec","article-title":"Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells","volume":"99","author":"Zeng","year":"2006","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.lfs.2022.120918_bb0260","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke Statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2022.120918_bb0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0163-7258(99)00029-7","article-title":"Dopamine receptors-physiological understanding to therapeutic intervention potential","author":"Emilien","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2022.120918_bb0270","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0008-6363(00)00044-4","article-title":"Angiotensin II, adhesion, and cardiac fibrosis a a","author":"Schnee","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2022.120918_bb0275","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.lfs.2022.120918_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172549","article-title":"Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-\u03b21 signaling pathway","volume":"859","author":"Ding","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120918_bb0285","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","article-title":"Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation","author":"Gibb","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2022.120918_bb0290","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yjmcc.2013.10.019","article-title":"Myofibroblasts: trust your heart and let fate decide","author":"Davis","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2022.120918_bb0295","doi-asserted-by":"crossref","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-specific TGF-\u03b2-Smad2\/3 signaling underlies cardiac fibrosis","author":"Khalil","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.lfs.2022.120918_bb0300","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.diabres.2017.08.018","article-title":"Transforming growth factor beta (TGF-\u03b2) mediates cardiac fibrosis and induces diabetic cardiomyopathy","author":"Yue","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.lfs.2022.120918_bb0305","doi-asserted-by":"crossref","DOI":"10.1007\/s10741-018-9720-1","article-title":"Biomarkers for the identification of cardiac fibroblast and myofibroblast cells","author":"Tarbit","year":"2019","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.lfs.2022.120918_bb0310","series-title":"The Cardiac Fibroblast","first-page":"29","article-title":"Cardiac remodeling and fibrosis: role of myofibroblasts","volume":"458","author":"Katwa","year":"2011"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052200618X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052200618X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:00:45Z","timestamp":1758402045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052200618X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":62,"alternative-id":["S002432052200618X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120918","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine receptor 3: A mystery at the heart of cardiac fibrosis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120918"}}